Skip to main content
. 2026 Oct 2;14(10):2235. doi: 10.3390/biomedicines14102235
AEs Adverse events
AF Annulus fibrosus
aRR Adjusted Risk Ratio
BP Biological Process
CC Cellular Component
CEP Cartilaginous endplate
CI Confidence Interval
DMEM Dulbecco’s Modified Eagle Medium
DPBS Dulbecco’s phosphate-buffered saline
ECM Extracellular matrix
EVs Extracellular vesicles
GO Gene Ontology
hPL Human platelet lysate
MF Molecular Function
MMPs Matrix metalloproteinases
MSCs Mesenchymal stem cells
NP Nucleus pulposus
NTA Nanoparticle tracking analysis
ODI Oswestry Disability Index
Q1 First Quartile
Q3 Third Quartile
RNA Ribonucleic acid
ROS Reactive oxygen species
RR Risk Ratio
SAE Serious Adverse Event
SEC Size exclusion chromatography
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
TFF Tangential flow filtration
VAS Visual Analog Scale
WJ-MSCs Wharton’s jelly-derived mesenchymal stem cells